PHARMALEADS

Patent Applications and Registrations

Patent applications and USPTO patent grants for PHARMALEADS.The latest application filed is for "n-formylhydroxylamines as neprilysin (nep) inhibitors, in particular as mixed aminopeptidase n (apn) and neprilysin (nep) inhibitors".

Company Profile

6.14.20

PHARMALEADS - Paris FR
PHARMALEADS -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
N-formylhydroxylamines As Neprilysin (nep) Inhibitors, In Particular As Mixed Aminopeptidase N (apn) And Neprilysin (nep) Inhibitors App 20220289668 - Poras; Herve ; et al.	2022-09-15
Aminophosphinic derivatives for preventing and treating eye inflammation Grant 11,090,317 - Poras , et al. August 17, 2	2021-08-17
Aminophosphinic Derivatives For Preventing And Treating Eye Inflammation App 20210213036 - PORAS; Herve ; et al.	2021-07-15
Amino Acid Derivatives Containing A Disulfanyl Group In The Form Of An Nep And Apn Inhibitor For The Prevention And Treatment Of Trigeminal Nerve Pain App 20210052539 - Poras; Herve ; et al.	2021-02-25
Methods of treating eye pain with aminophosphinic derivatives Grant 10,688,113 - Poras , et al.	2020-06-23
Industrial process for the preparation of (5S, 10S)-10-benzyl-16-methyl-11, 14, 18-trioxo-15, 17, 19-trioxa-2,7,8-trithia-12-azahenicosan-5-aminium(E)-3-carboxyacrylate salt Grant 10,399,936 - Poras , et al. Sep	2019-09-03
Methods of Treating Eye Pain With Aminophosphinic Derivatives App 20190167701 - PORAS; Herve ; et al.	2019-06-06
Aminophosphinic Derivatives For Preventing And Treating Eye Pain App 20180344753 - PORAS; Herve ; et al.	2018-12-06
Aminophosphinic derivatives that can be used in the treatment of pain Grant 10,131,681 - Roques , et al. November 20, 2	2018-11-20
Industrial Process For The Preparation Of (5s, 10s)-10-benzyl-16-methyl-11, 14, 18-trioxo-15, 17, 19-trioxa-2,7,8-trithia-12-azahenicosan-5-aminium(e)-3-carboxyacrylate Salt App 20180305308 - PORAS; Herve ; et al.	2018-10-25
Mixed inhibitors of aminopeptidase N and neprilysin Grant 9,388,129 - Roques , et al. July 12, 2	2016-07-12
Agents for the molecular imaging of serine-protease in human pathologies Grant 9,272,054 - Michel , et al. March 1, 2	2016-03-01
Mixed Inhibitors Of Aminopeptidase N And Neprilysin App 20150299116 - ROQUES; Bernard Pierre ; et al.	2015-10-22
Aminophosphinic Derivatives That Can Be Used In The Treatment Of Pain App 20140161839 - Roques; Bernard ; et al.	2014-06-12
Aminophosphinic derivatives that can be used in the treatment of pain Grant 8,703,747 - Roques , et al. April 22, 2	2014-04-22
Agents For The Molecular Imaging Of Serine-protease In Human Pathologies App 20130243691 - Michel; Jean-Baptiste ; et al.	2013-09-19
Substrates The Fluorescence Of Which Is Suppressed, Preparation Thereof, And Use Thereof For Identifying, Detecting, And Assaying Legionella Pneumophilia App 20130203097 - Poras; Herve ; et al.	2013-08-08
Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase N inhibitors Grant 8,247,608 - Roques , et al. August 21, 2	2012-08-21
Aminophosphinic Derivatives That Can Be Used In The Treatment Of Pain App 20110124601 - Roques; Bernard ; et al.	2011-05-26
Novel Amino Acid Derivatives, Method For Preparing Same, And Therapeutic Use Thereof App 20110071218 - Fournie-Zaluski; Marie-Claude ; et al.	2011-03-24
Peptide substrates recognizable by a botulinum toxin A, BoNT/A and the use thereof Grant 7,875,436 - Fournie-Zaluski , et al. January 25, 2	2011-01-25
Aminoacid Derivatives Containing a Disulfanyl Group in the form of Mixed Disulfanyl and Aminopeptidase N Inhibitors App 20090131509 - Roques; Bernard ; et al.	2009-05-21
Aminoacid Derivatives Containing A Disulfanyl Group In The Form Of Mixed Disulfanyl And Aminopeptidase N Inhibitors App 20090012153 - Roques; Bernard ; et al.	2009-01-08

Company Registrations

NCAGE Code	FBBG2	PHARMALEADS
CAGE Code	FBBG2	PHARMALEADS
S.A.M. Registration	FBBG2 [397640629]	PHARMALEADS

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.